(R)-2-Flurbiprofen
| CAS No. | 51543-40-9 | Cat. No. | BCP13426 |
| Name | (R)-2-Flurbiprofen | ||
| Synonyms | (R)-Flurbiprofen;E7869; Tarenflurbil; MPC7869;MPC 7869; MPC-7869;E7869;E 7869; | ||
| Formula | C15H13FO2 | M. Wt | 244.26 |
| Description | (R)-Flurbiprofen is an orally active synthetic enantiomer of flurbiprofen. Tarenflurbil activates c-Jun N terminal kinase, increases AP-1 binding to DNA, and downregulates cyclin D1 expression, resulting in arrest of tumor cells in the G1 phase of the cell cycle and apoptosis. This agent also affects the expression of nuclear factor kappa B, a rapid response transcription factor that stimulates the immune response to tumor cells. Tarenflurbil does not inhibit the enzyme cyclo-oxygenase. Tarenflurbil is currently tested in patients with mild Alzheimer's disease. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | RAR/RXR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.